Search results for drug development
AI & Enterprise
MegazoneCloud wins Snowflake Partner of the Year award, plans to expand use cases
MegazoneCloud said on Thursday it has won global AI data cloud company Snowflake\'s Partner of the Year award. It is the second consecutive year it has received the award. The company said it was recognised for supporting Snowflake-based data platform builds and data and AI transformation, and for contributing to the expansion of the partner ecosystem. MegazoneCloud said it plans to broaden deployments into pharmaceuticals and biotechnology, including regulatory and quality work.
AI & Enterprise
KAIST to build AI, robot-based autonomous lab with Thermo Fisher Scientific
Korea Advanced Institute of Science and Technology (KAIST) plans to build an AI- and robot-driven autonomous laboratory with Thermo Fisher Scientific. The partners will jointly create the SHARE Hub, which connects human intuition, AI reasoning, robotic experiments and experimental data. Under the system, researchers pose scientific questions, AI designs experiments, robots run them and AI analyses results to guide subsequent tests. They also plan joint development and a challenge programme.
AI & Enterprise
OpenAI to lease 10-GW Ohio data centre for 20 years; Nvidia to guarantee up to $105 billion in rent
OpenAI will lease for 20 years a 10-gigawatt AI data centre campus being built in Ohio, with Nvidia investing $1.5 billion and taking on a rent guarantee of up to $105 billion. SoftBank Group unit SB Energy will develop, own and operate the site. The project includes new power generation and grid investment, with phased construction starting in 2028. The deal also includes a loss-compensation clause tied to OpenAI’s lease.
-
AI & Enterprise
South Korea\'s science ministry reopens search for K-Moonshot AI Scientist project director
-
AI & Enterprise
Google Alphafold team effectively dismantled, staff reassigned to Gemini
-
AI & Enterprise
OpenAI offers advanced AI tools free to academic researchers for one year
-
AI & Enterprise
SKT steps up industrial deployment of A.X K2, accelerating global AI race
-
Industry
U.S. biotech Axiom chooses Hong Kong over Nasdaq for first listing
-
Industry
MSIT steps up \'K-Moonshot\' AI drug mission with stakeholder meeting
-
AI & Enterprise
SK Telecom, SK Biopharm find early drug candidates for hard-to-treat cancer with AI
-
People
Vice minister Goo reviews national new drug development results, says AI will speed innovation
-
AI & Enterprise
Lunit, KAIST step up pilot tests and model upgrades ahead of specialised foundation model final review
-
AI & Enterprise
MSIT overhauls K-Moonshot rules to build PD-led accountability system
-
AI & Enterprise
Quantum computer investment race heats up, but experts say there is still no use for it
-
AI & Enterprise
Interbiz Bio Forum opens in Jeju to discuss investment cooperation
-
AI & Enterprise
Anthropic launches in-house AI drug discovery program to target neglected diseases
-
Industry
MSIT to boost bio CMC capabilities, push new project with MOTIE
-
Industry
Samsung Galaxy Watch biometric data to be used as metrics for new drug efficacy and safety